If you are interested in these peptide products, please contact roleagh@gmail.com
Classification of Polypeptide API
US-DMF LIST
| US-DMF LIST–Polypeptide API | ||
|---|---|---|
| Product Name | US-DMF No. | WC |
| Bivalirudin | DMF 25531 | YES |
| Eptifibatide | DMF 27651 | YES |
| Liraglutide | DMF 29302 | YES |
| Icatibant Acetate | DMF 28496 | YES |
| Octreotide Acetate | DMF 30249 | YES |
| Teriparatide Acetate | DMF 32144 | |
| Ziconotide Acetate | DMF 33139 | |
| * | * |
Chinese cGMP APIs
| Chinese cGMP APIs--Polypeptide API | ||
|---|---|---|
| Product Name | GMP Certificate No. | WC |
| Levosimendan | SC20120022 | |
| Thymosin alpha1 | SC20140047 | |
| Enfuvirtide | SC20140098 | |
| Octreotide Acetate | SC20150121 | YES |
| Somatostatin | SC20150121 | |
| Thymopentin | SC20150121 | |
| Carbetocin | SC20160013 | |
| Atosiban | SC20170065 |
Research Polypeptide APIs for Regulatory Market
| Research Polypeptide APIs for Regulatory Market | |
|---|---|
| Product Name | US-DMF Time Point |
| Linaclotide | Before the end of 2019 |
| Ganirelix | Before the end of 2019 |
| Degarelix | Before the end of 2020 |
| Exenatide | Before the end of 2021 |
| Teduglutide | Before the end of 2021 |
| Cetrorelix | Before the end of 2021 |
| Semaglutide | Before the end of 2022 |
Mexico Registered APIs –Polypeptide APIs
| Mexico Registered APIs –Polypeptide API | |
|---|---|
| Product Name | GMP Certificate No. |
| Levosimendan | SC20120022 |
| Enfuvirtide | SC20140098 |
| Bivalirudin | DMF 25531 |
| Eptifibatide | DMF 27651 |
| Liraglutide | DMF 29302 |
| Icatibant Acetate | DMF 28496 |
| Octreotide Acetate | DMF 30249SC20150121 |
| Peptide API | |
|---|---|
| Product name | Serial number |
| Alarelin Acetate | 79561-22-1 |
| Angiotensin Acetate | 20071-00-5 |
| Argipressin Acetate | 113-79-1 |
| Atosiban Acetate | 90779-69-4 |
| Trifluoro Acetate | 128270-60-0 |
| Cetrorelix Acetate | 120287-85-6 |
| Deslorelin Acetate | 57773-65-6 |
| Desmopressin Acetate | 16789-98-3 |
| Elcatonin Acetate | 57014-02-5 |
| Enfuvirtide Acetate | 159519-65-0 |
| Eptifibatide Acetate | 148031-34-9 |
| Exenatide Acetate | 141732-76-5 |
| GLP-1(7-36) | 107444-51-9 |
| Glucagon Acetate | 16941-32-5 |
| Gonadorelin Acetate | 71447-49-9 |
| Leuprorelin Acetate | 53714-56-0 |
| Lysipressin Acetate | 50-57-7 |
| Nesiritide Acetate | 114471-18-0 |
| Octreotide Acetate | 83150-76-9 |
| Oxytocin Acetate | 50-56-6 |
| Pramlintide Acetate | 196078-30-5 |
| Salcitonin Acetate | 47931-85-1 |
| Secretin Acetate | 17034-35-4 |
| Sermorelin Acetate | 86168-78-7 |
| Somatostatin Acetate | 38916-34-6 |
| Teriparatide Acetate | 52232-67-4 |
| Terlipressin Acetate | 14636-12-5 |
| Tetracosactide Acetate | 16960-16-0 |
| Thymopentin | 69558-55-0 |
| Thymosin α1 Acetate | 62304-98-7 |
| Triptorelin Acetate | 57773-63-4 |
| Ziconotide Acetate | 107452-89-1 |
| CJC-1295 | |
| Buserelin Acetate | 68630-75-1 |
| MOG (35-55) | 149635-73-4 |
| Ghrelin(Human) Acetate | 304853-26-7 |
Shengnuo bio PRODUCT
Best sales manager contact
| Contacts | Roleagh |
|---|---|
| Tel | 86-28-88203630 |
| Fax | 86-28-88203630 |
| roleagh@gmail.com | |
| 2539328606 | |
| LEI LI |
About Shengnuo
Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.